RE:Phase 2 trial still not recruitingGrahamB wrote: According to Clinical trials.gov
https://www.clinicaltrials.gov/ct2/show/results/NCT04619706?cond=Palmitoylethanolamide&draw=2&rank=8
Meanwhile...
UK has started to vaccinate people today outside of trials
US just announced approval of vaccines with dosing expected within days
Canada very soon
Great news for the battle to defeat COVID
FSD is lagging again
Will we hear, as we did for Cannabis....
Its too competitive
Let's do a trial in....
'Let's keep burning cash...
'Let's reward the board with more shares for having the wisdom to see this...
Let's see
Read the report with interest.
Some of us came to the same conclusion about the failure of FSD with Covid and nPEA-but I guess they needed to hire multiple groups to find out what was self evident.
Lets see- can we imagine what they will say when LUCID fails???
"The biotechnology investment bank reported its findings and the Company concluded that, while there are potential commercial opportunities for FSDPEA, the treatment of COVID19 by FSDPEA is unlikely to be commercially viable. Between big pharma and higher vaccination rates worldwide, by the time a Phase 3 study is complete, it would be too late. Based on this information, on August 24, 2021, FSD Pharma elected to terminate its current Phase 2 clinical trial for the treatment of COVID19 to concentrate its resources on commercially viable opportunities for FSDPEA and best return for its investment"